Market closed · data as of 27 Aug 2026 · source NSE via Alphave. Open the live chart →
Diagnostics chain offering both pathology (blood tests) and radiology (X-ray, ultrasound, CT, MRI, PET-CT) under one roof through a hub-and-spoke network of diagnostic centres, concentrated in Hyderabad and Andhra Pradesh/Telangana with expansion into other southern and western markets. A predominantly B2C walk-in model with high radiology mix versus pathology-led peers. Revenue is driven by centre additions, test volumes and wellness packages.
The leading integrated diagnostics chain in the Hyderabad/AP-Telangana region with an unusually radiology-heavy, B2C-centric model.
Vijaya Diagnostic Centre Ltd. is a constituent of NIFTY 500, NIFTY SMALLCAP 250. See where it sits on the market heatmap →
Consolidated annual figures taken from Vijaya Diagnostic Centre Ltd.'s own filed statements — not estimates, and not restated by us. The most recent period shown is FY26 (year ended 31 Mar 2026).
| Metric | FY26 | FY25 | FY24 |
|---|---|---|---|
| EPS (basic, ₹) | 16.81 | 13.95 | 11.62 |
| Book value / share (₹) | 93.02 | 77.86 | 64.48 |
| Return on equity | 18.1% | 17.9% | 18.0% |
| Return on capital employed | 17.7% | 18.2% | 18.0% |
| Operating margin | 30.1% | 29.7% | 29.9% |
| Net margin | 21.2% | 21.1% | 21.8% |
| EBITDA | ₹337 Cr | ₹273 Cr | ₹221 Cr |
| Free cash flow | ₹88 Cr | ₹129 Cr | ₹95 Cr |
| Total debt | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Debt to equity | 0.00 | 0.00 | 0.00 |
| Interest coverage | 7.4 | 7.6 | 6.8 |
| Current ratio | 2.60 | 1.89 | 2.90 |
| Shares outstanding | 10,28,97,000 | 10,26,37,000 | 10,23,46,000 |
Open the full income statement, balance sheet and cash flow for VIJAYA →
As disclosed for the quarter ended 30 Jun 2026.
Institutional ownership changes quarter to quarter. See daily FII and DII flows across the market →
Companies Alphave classifies in the same sub-sector, closest by market capitalisation.